Overview Fundamentals Financials Technicals Corporate Action Shareholding Pattern Peer Comparison News Stock Analysis About Company FAQs

Venus Remedies Ltd Share Price

Pharmaceuticals - I V Fluids

NSE: VENUSREM Small Cap ISIN: INE411B01019
As on 31 January 2025 at 14:14 IST
As on 31 January 2025 at 14:14 IST
297.25
+ 1.40
(0.47%)
Over 1 Month
-4.58%
Over 6 Months
-27.87%
Over 1 Year
-21.04%
Over 3 Years
-12.99%

Venus Remedies Ltd Summary

Close ₹ 297.25
Open ₹ 297.55
High ₹ 300
Low ₹ 292.15
Volume 5,615
Net Turnover (in ₹ Cr) ₹ 0.25
52Wk High ₹ 427.90
52Wk Low ₹ 270.25
52Wk High / Low
270.25
427.90

Venus Remedies Ltd Fundamentals

Key Financial Data

Market Cap (in ₹Cr) ₹ 395.46
EPS (TTM) 25.74
Book Value (BV) 392.45
Div. Yield -
P/E (TTM) 11.46
Price/Book Value 0.75
Delivery % 54.05 %
Face Value 10

Key Ratios

PE Ratio 14.30
PB Ratio 0.86
EV to Sales 0.71
PEG Ratio 2.69
ROA 5.47
ROE 6.18
Debt-Equity 0.08
Net Profit Margin 5.30
Operating Profit Margin 12.55

Venus Remedies Ltd Financials

Profit and Loss

Particulars (in ₹ Cr.) FY 2024FY 2023FY 2022FY 2021FY 2020
Total Revenue613.03565.83608.49567.75344.64
Total Expenses568.39527.90572.08542.64343.87
Profit Before Tax44.6437.9336.4148.55-8.04
Profit After Tax28.4926.5740.7261.77-10
Operating Profit after Depreciation44.7438.0536.8938.1314.11

Balance Sheet

Particulars (in ₹ Cr.) FY 2024FY 2023FY 2022FY 2021FY 2020
Fixed Assets218.53215.96240.94261.68289.37
Total Non Current Assets267.30278.25301.78321.82349.77
Total Current Assets359.52322.83278.04234.03294
TOTAL ASSETS626.82601.08579.82555.85643.77
Total Shareholder's Fund487.55460.34440.45400.28323.37

Cash Flow

Particulars (in ₹ Cr.) FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash from Operating Activities37.2936.6341.10131.8477.60
Net Cash used in Investing Activities-8.46-58.10-17.2557.34-4.69
Net Cash used in Financing Activities-1.08-0.57-9.48-162.24-73

Particulars (in ₹ Cr.) FY 2024FY 2023FY 2022FY 2021FY 2020
Total Revenue586.53547.84585.14532.39323.81
Total Expenses539.88507.51540.47514.77321.26
Profit Before Tax46.6540.3344.6741.06-6.26
Profit After Tax30.5028.9648.9954.27-8.23
Operating Profit after Depreciation46.6540.3344.6730.3415.59

Balance Sheet

Particulars (in ₹ Cr.) FY 2024FY 2023FY 2022FY 2021FY 2020
Fixed Assets202.76199.68224.67244.20271.47
Total Non Current Assets280.26290.70314.25333.08360.33
Total Current Assets361318.19264.41213.74283.94
TOTAL ASSETS641.26608.89578.66546.81644.27
Total Shareholder's Fund508.59478.05449.41400.18332.25

Cash Flow

Particulars (in ₹ Cr.) FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash from Operating Activities35.3828.0541132.3477.75
Net Cash used in Investing Activities-6.94-50.81-16.7555.98-4.64
Net Cash used in Financing Activities---9.13-161.88-72.35

Particulars (in ₹ Cr.) 2024-09 2024-06 2024-03 2023-12 2023-09
Total Revenue167.45108.61195.16143.42167.72
Total Expenses162.5397.35175.69131.43149.93
Profit Before Tax9.076.8517.467.7814.34
Profit After Tax3.511.2210.516.859.94
Operating Profit after Depreciation15.5012.8523.3914.3420.84

Particulars (in ₹ Cr.) 2024-09 2024-06 2024-03 2023-12 2023-09
Total Revenue167.02105.86175.16131.23170.19
Total Expenses156.7791.58153.89118.23157.06
Profit Before Tax14.8110.0819.469.129.85
Profit After Tax9.264.4512.518.195.45
Operating Profit after Depreciation20.9615.8425.1815.4216.06

Venus Remedies Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3
S1 291.02
S2 286.18
S3 280.47
Pivot 296.73
R1 301.57
R2 307.28
R3 312.12

Moving Average

20 SMA 296.43
50 SMA 308.90
100 SMA 320.39
200 SMA 334.90

Venus Remedies Ltd Corporate Actions

No available data

Venus Remedies Ltd Peer Comparison

Company Price Market Cap (in ₹ Cr)
Venus Remedies Ltd ₹295.05 ₹394.39
Sun Pharmaceuticals Industries Ltd ₹1,745.25 ₹4,18,743.94
Divis Laboratories Ltd ₹5,733.60 ₹1,52,209.07
Cipla Ltd ₹1,458.15 ₹1,17,762.24
Torrent Pharmaceuticals Ltd ₹3,357.15 ₹1,13,616.11
Mankind Pharma Ltd ₹2,488.40 ₹1,02,663.15

Venus Remedies Ltd News

Venus Remedies to announce Quarterly Result

On 4 February 2025

25 Jan 2025, 09:23 am

Venus Remedies jumps after renewing EU GMP certification

Venues remedies rallied 5.30% to Rs 310.95 after the company successfully renewed its European good manufacturing practices (GMP) certification by infarmed, the national health authority of Medicines and Health products in Portugal.

21 Jan 2025, 11:48 am

Venus Remedies rallies after receiving GMP certificate for antibiotic-Carbapenem facility.

Venus Remedies jumepd 3.40% to Rs 321 after the company received good manufacturing practice (GMP) certification from Ministry of Health of Moldova for the company's antibiotic -Carbapenem facility.

31 Dec 2024, 01:43 pm

Venus Remedies to table results

On 29 October 2024

18 Oct 2024, 05:16 pm

Venus Remedies AGM scheduled

On 23 September 2024

24 Aug 2024, 10:36 am

Venus Remedies Ltd Stock Analysis

  1. Annual revenue for Venus Remedies Ltd increased by 7.06% to ₹586.53 crore in FY 2024 from ₹547.84 crore in FY 2023.
  2. Annual Net Profit for Venus Remedies Ltd increased by 5.30% to ₹30.50 crore in FY 2024 from ₹28.96 crore in FY 2023.
  3. Promoter Shareholding in Venus Remedies Ltd remains unchanged by 0.00% in the most recent quarter, from 41.76% in September 2024 to 41.76% in December 2024.
  4. Venus Remedies Ltd delivered a 1-year return of -21.04% compared to the Nifty 50, which provided a return of 8.03% as of the last trading session.
  5. Venus Remedies Ltd share price moved up by 0.47% from its previous close of INR ₹295.85. The latest Venus Remedies Ltd share price is INR ₹297.25.
  6. Venus Remedies Ltd share price today has been at a low of 292.15 and a high of 300. Over the past 52 weeks, the Venus Remedies Ltd share price has seen a low of 270.25 and a high of 427.90.

FAQ’s

What is the share price of Venus Remedies Ltd today?

Venus Remedies Ltd share price as on 31 Jan 2025 is ₹ 297.25

What is the Market Cap of Venus Remedies Ltd?

The market cap of Venus Remedies Ltd stock is ₹395.46 Cr.

What is the PE Ratio of Venus Remedies Ltd?

The Price to Earnings (P/E) Ratio of Venus Remedies Ltd is 14.30

What is the PB Ratio of Venus Remedies Ltd?

The Price to Book (P/B) Ratio of Venus Remedies Ltd is 0.86

What is the 52 week high of Venus Remedies Ltd Share Price?

The 52 week high of Venus Remedies Ltd share price stands at ₹427.90

What is the 52 week low of Venus Remedies Ltd Share Price?

The 52 week low of Venus Remedies Ltd share price stands at ₹270.25

Get started with us today and
start building your wealth journey